Zoladex 10.8 MG implant syrns
Ended Awarded Last action
- Contract number
- SPE2DR26FU393
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,637
Award facts
- Contract value 100% obligated
- $17,636.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,636.58 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This competitively awarded, firm fixed-price contract was executed on December 3, 2025, with an ultimate completion date of December 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. Zoladex, a hormone treatment used in cancer therapy and other endocrine conditions, represents the type of specialized pharmaceutical commodity that AmerisourceBergen regularly supplies to support military and veteran healthcare programs. The company's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its capability to meet federal procurement requirements and fulfill the diverse medical supply needs of defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FU393?
SPE2DR26FU393 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FU393 worth?
The government has obligated $17,637 on SPE2DR26FU393.
Is contract SPE2DR26FU393 an order under another contract?
Yes. SPE2DR26FU393 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU393 competed?
The extent of competition for SPE2DR26FU393 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award